In conclusion, the study demonstrated that preoperative serum levels of CEA and CA15-3 had an independent association with molecular subtypes of breast cancer with high level of CEA in Her-2-positive patients (luminal B Her-2 positive and Her-2 overexpression). This evidence concerns the gene ERBB2 and breast carcinoma.